Anthropic and Nvidia Back Basecamp Research in $140M Series C

Basecamp Research has closed a $140 million Series C round with backing from Anthropic and Nvidia, according to Tech.eu.

The round marks one of the larger recent financings for a company operating at the intersection of biological data and artificial intelligence. Anthropic and Nvidia, two of the most closely watched names in AI, put capital behind the startup. Their participation signals strategic interest, not just passive financial exposure, from companies at the center of the current AI buildout.

The $140 million figure makes the deal a Series C, placing Basecamp Research in the tier of startups that have moved beyond early-stage validation. The company's earlier investors and its precise valuation were not disclosed in the report.

Basecamp Research has built its business around biological data. The startup collects and structures data from the natural world — field samples, protein information and related datasets — and packages it for use in AI-driven scientific research. That positioning has drawn attention as pharmaceutical companies, materials firms and AI laboratories compete for high-quality, proprietary training data that generic internet-scale datasets cannot supply.

The involvement of Anthropic is notable. The company, best known for its Claude family of large language models, has generally focused its capital on computing infrastructure and AI safety research. A direct investment in a biological-data company suggests Anthropic sees value in specialized data sources for frontier models — or in the applications those models can unlock in life sciences.

Nvidia's participation fits a broader pattern. The chipmaker, whose GPUs power most large-scale AI training, has become one of the most active corporate investors in the AI ecosystem, backing companies that expand demand for accelerated computing. Biology and drug discovery have become a priority area for Nvidia, whose executives have repeatedly pointed to life sciences as a major future market for AI infrastructure.

The $140 million round gives Basecamp Research fresh ammunition to expand data collection, deepen its AI capabilities and scale commercial relationships. Companies in its category typically use growth capital of this size to fund field expeditions, expand engineering teams and sign multi-year data contracts with industrial and academic partners.

The financing also lands amid intensifying competition for foundational biological datasets. Large AI developers have moved to secure specialized data — protein structures, genomic sequences, environmental samples — that can differentiate models in scientific domains. Startups that control such data pipelines have attracted premium valuations as a result.

For Anthropic and Nvidia, the deal is a relatively contained bet within their broader investment portfolios, but it aligns with a clear thesis: the next wave of AI value may come less from general-purpose language models and more from domain-specific data that those models can exploit. Basecamp Research's field-data model sits squarely in that thesis.

Tech.eu, which first reported the round, did not disclose additional terms, including whether the financing included secondary shares or new board seats for the investors.

The Series C sets up Basecamp Research for a scaling phase in which it must convert its data advantage into durable revenue — and demonstrate to its new backers from the AI establishment that biological data can be a foundational input for the next generation of models.